Clinical Trial Update: Phase II Trial of Pentostatin in Steroid Refractory Acute Graft Versus Host Disease [Phase 2]

View source ↗

Summary

Phase II trial evaluating pentostatin for steroid-refractory acute graft-versus-host disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Pentostatin (pentostatin)

Snippet

Sponsor: Ohio State University Comprehensive Cancer Center | Conditions: Graft-Versus-Host Disease | Phase 2 | Status: COMPLETED